Monthly Subscription
Unlimited document downloads
$99


Custom Document Search
Locate hard-to-find documents, quickly and inexpensively
$59

See also:

company_intel Neurocrine Biosciences, Inc.


The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$39
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Consent and Agreement DOV Pharma;
Merck 		Neurocrine;
Wyeth
$39
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Consent and Agreement Abbott Labs;
Aventis Pharma;
DOV Pharma 		Neurocrine
Entity 2 3
$39
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Opinion Letter Re: $200,000,000 Aggregate Offering Price of Securities Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$31
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Opinion Letter Re: $200,000,000 Aggregate Offering Price of Securities Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$31
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Opinion Letter Re: $28,562,500 Aggregate Offering Price of Securities Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$30
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Opinion Letter Re: Form S-8 Registration Statement Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$40
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence Opinion Letter Re: Form S-8 Registration Statement Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$38
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence Opinion Letter Re: Form S-8 Registration Statement Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$34
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Opinion Letter Re: Form S-8 Registration Statement Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$33
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Opinion Letter Re: Form S-8 Registration Statement Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$38
 Subscribers Subscribers
Preview 		2000
 ContractIntelligence Opinion Letter Re: Registration Statement No. 333-47252; 3,450,000 Shares Of Common Stock, par Value $0.001 per Share Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$37
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Opinion Letter Re: Registration Statement on Form S-3; 287,500 Shares of Common Stock, Par Value $.001 per Share Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$38
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Opinion Letter Re: Registration Statement on Form S-3; 3,737,500 Shares of Common Stock, par Value $.001 per Share Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$37
 Subscribers Subscribers
Preview 		2000
 ContractIntelligence Opinion Letter Re: Registration Statement on Form S-8 Neurocrine Biosciences, Inc. Law FirmLatham & Watkins
$37
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Tax Indemnity Agreement Gary Lyons Neurocrine Biosciences, Inc.
$37
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Tax Indemnity Agreement Paul W. Hawran Neurocrine Biosciences, Inc.
$37
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Tax Indemnity Agreement Margaret Valeur-Jensen Neurocrine Biosciences, Inc.
$37
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Tax Indemnity Agreement Kevin Gorman Neurocrine Biosciences, Inc.
$37
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Tax Indemnity Agreement Paul Conlon;
PDC, LLC 		Neurocrine